Clinical trials for Cancer in United States

Trial Of PreoperAtive Radiation (TOPAz): A Randomized Trial Comparing Hypofractionated Versus Conventionally Fractionated Preoperative Radiation Followed by Mastectomy With Immediate Autologous Breast Reconstruction With Integrated Nanomechanical Biomarker Evaluation

Study ID: NCT05774678

Sponsor

M.D. Anderson Cancer Center

Repurposing Atovaquone for the Treatment of Platinum-Resistant Ovarian Cancer

Study ID: NCT05998135

Sponsor

Emory University

Metabolic Biomarkers in Thoracic Cancers

Study ID: NCT02095808

Sponsor

University of Texas Southwestern Medical Center

Phase II Study of Pirtobrutinib, Rituximab (PR) in Previously Untreated Low and Intermediate Risk MCL (Mantle Cell Lymphoma) Patients

Study ID: NCT06263491

Sponsor

M.D. Anderson Cancer Center

Dasatinib and Quercetin With CAR-T Therapy for the Treatment of Patients With Relapsed or Refractory Multiple Myeloma

Study ID: NCT06940297

Sponsor

Mayo Clinic

Observational Lung Trial to Collect Tissue to Train and Validate a Live Tumor Diagnostic Platform

Study ID: NCT05478538

Sponsor

the elephant

A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.

Study ID: NCT05967689

Sponsor

Taiho Oncology, Inc.

Open-label, Single Center, Single-arm, Phase 2 Study of Neoadjuvant Pembrolizumab in Combination With Carboplatin and Paclitaxel in Patients With Stage 1 cT1b-T1cN0M0 Triple Negative Breast Cancer

Study ID: NCT06318897

Sponsor

M.D. Anderson Cancer Center

UCDCC#272: IL-2, Radiotherapy, and Pembrolizumab in Patients Refractory to Checkpoint Blockade

Study ID: NCT03474497

Sponsor

Megan Daly, MD

A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

Study ID: NCT05552222

Sponsor

Janssen Research & Development, LLC